Related Experiment Video
Updated: Mar 23, 2026

09:03
Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
10.0K
Amplicon-based semiconductor sequencing of human exomes: performance evaluation and optimization strategies
E Damiati1, G Borsani1, Edoardo Giacopuzzi2
1Unit of Genetics, Department of Molecular and Translational Medicine, University of Brescia, 25123, Brescia, Italy.
Human Genetics
|March 23, 2016
Summary
This study evaluates whole exome sequencing (WES) on the Ion Proton platform using AmpliSeq Exome kits and HiQ chemistry. A filtering strategy significantly reduces false-positive variants, enhancing accuracy for genetic variant identification.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- The Ion Proton platform offers cost-effective whole exome sequencing (WES) with rapid turnaround.
- AmpliSeq Exome kits and HiQ sequencing chemistry are key components for WES on this platform.
- Accurate variant identification is crucial for clinical applications of WES.
Purpose of the Study:
- To assess the performance of Ion Proton WES for variant identification using gold-standard data.
- To characterize erroneous variant calls and develop a filtering strategy to minimize false positives.
- To evaluate the impact of sequencing depth and capture efficiency on variant detection.
Main Methods:
- Whole exome sequencing was performed on the Ion Proton platform.
- The AmpliSeq Exome kit was used for library preparation.
- Performance was evaluated using variants from the Genome in a Bottle (GIAB) consortium.
- Variant identification accuracy was assessed at different sequencing coverages.
- A filtering strategy was developed and applied to reduce false-positive variant calls.
Main Results:
- The AmpliSeq Exome kit captures over 94% of human coding bases, with some genes showing incomplete representation.
- Optimal variant detection performance was achieved at mean coverage >120×.
- HiQ chemistry demonstrated sensitivities of ~71% for indels and ~97.5% for SNPs.
- The proposed filtering strategy reduced false positives by up to 40.4% for indels and 68.2% for SNPs.
- Higher sequencing coverage (>120×) improved variant detection accuracy.
Conclusions:
- Amplicon-based WES on the Ion Proton platform with HiQ chemistry is a competitive approach for variant identification.
- While false positives remain a challenge for Ion Torrent technology, the developed filtering strategy effectively reduces erroneous calls.
- The platform shows promise for cost-effective and accurate genetic variant analysis, particularly with optimized sequencing depth and filtering.
Related Concept Videos
RNA-seq
12.4K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.4K
Sanger Sequencing
778.0K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
778.0K
Next-generation Sequencing
100.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
100.8K
Maxam-Gilbert Sequencing
13.6K
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
Challenges of the Maxam-Gilbert Method
The...
13.6K

